Discontinuing cholinesterase inhibitor vs continued cholinesterase inhibitor
Adverse events (any) · people with dementia
Discontinuing cholinesterase inhibitor showed no clear difference in adverse events (any) compared with continued cholinesterase inhibitor (low certainty).
1 finding from 1 review
- Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia 2021 · Cochrane Headline outcomes onlyOR 0.85 [0.57, 1.27]4 studies · 446 participantsLow